Franzén Boger, Mathias
Benhach, Nora
Hasselrot, Tyra
Brand, Rhonda M.
Rohan, Lisa C.
Wang, Lin
McGowan, Ian
Edick, Stacey
Ho, Ken
Meyn, Leslie
Matoba, Nobuyuki
Palmer, Kenneth E.
Broliden, Kristina
Tjernlund, Annelie
Funding for this research was provided by:
Physician against AIDS Foundation (FOb2021-0015)
Karolinska Institutet
National Institutes of Health (U19AI113182)
Swedish Research Council (2021-02671)
Karolinska Institute
Article History
Received: 13 December 2022
Accepted: 24 April 2023
First Online: 9 May 2023
Competing interests
: The authors declare no competing interests, except Dr. Ian McGowan who is a shareholder of, and acts as a consultant to, AELIX Therapeutics SL. He is also the CMO of Orion Biotechnology, outside the scope of the submitted work.